Pfizer Inc.
PFE
$25.74
$0.030.12%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/28/2025 | 06/29/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.66% | 6.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.66% | 6.84% | |||
| Cost of Revenue | 13.62% | 35.11% | |||
| Gross Profit | 13.67% | 0.25% | |||
| SG&A Expenses | -6.34% | 13.20% | |||
| Depreciation & Amortization | 0.99% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.15% | 17.52% | |||
| Operating Income | 39.78% | -12.86% | |||
| Income Before Tax | 9.53% | 9.34% | |||
| Income Tax Expenses | -253.19% | 174.60% | |||
| Earnings from Continuing Operations | 22.29% | -2.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 50.00% | -200.00% | |||
| Net Income | 21.68% | -1.92% | |||
| EBIT | 39.78% | -12.86% | |||
| EBITDA | 29.32% | -9.51% | |||
| EPS Basic | 21.68% | -2.08% | |||
| Normalized Basic EPS | 45.56% | -14.71% | |||
| EPS Diluted | 21.12% | -1.56% | |||
| Normalized Diluted EPS | 45.37% | -14.51% | |||
| Average Basic Shares Outstanding | 0.00% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.14% | -0.07% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -- | -- | |||